Detailed Description:
see brief summary
Inclusion Criteria:
- AML according to the WHO (World Health Organization) diagnostic criteria, including
acute promyelocytic leukemia
- Age ≥ 18 years. There is no upper age limit.
- Signed written informed consent
Exclusion Criteria:
- there are no exclusion criteria
Primary outcome:
1. Epidemiological parameters (Time Frame - 10 years):
Epidemiological parameters
2. Relapse free survival (RFS) (Time Frame - 10 years):
Relapse free survival
3. Time to relapse (TTR), (Time Frame - 10 years):
Time to relapse (TTR),
4. Overall Survival (OS) (Time Frame - 10 years):
Overall Survival (OS)
5. cumulative incidence of relapse (CIR) (Time Frame - 10 years):
cumulative incidence of relapse (CIR)
Secondary outcome:
1. Complete Remission (CR) (Time Frame - yearly follow up 10 years):
Complete Remission
2. Treatment related mortality (TRM) (Time Frame - yearly follow up 10 years):
Treatment related mortality
3. Therapy-associated morbidity (Time Frame - yearly follow up 10 years):
grade IV toxicities
4. Recording and evaluating the quality of therapy and diagnosis (Time Frame - 10 years):
Recording and evaluating the quality of therapy and diagnosis
5. Validation of published prognostic factors at the registry cohort and the search for new possible prognostic factors (Time Frame - 10 years):
Validation of published prognostic factors at the registry cohort and the search for new possible prognostic factors
6. Recording and describing new forms of therapy and new supportive measures (Time Frame - 10 years):
Recording and describing new forms of therapy and new supportive measures
Quelle: ClinicalTrials.gov